Peptide immunogens designed to enhance immune responses against human immunodeficiency virus (HIV) mutant strains: a plausible means of preventing viral persistence

A major problem impeding the development of an effective HIV-1 vaccine is the rapid antigenic variability that occurs throughout the viral genome but is most pronounced in the envelope ( env) gene and env gene products. The high number of errors made by the reverse transcriptase (RT) enzyme and the...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of theoretical biology 2005-03, Vol.233 (1), p.85-90
Hauptverfasser:	Hewer, R., Meyer, D.
Format:	Artikel
Sprache:	eng
Schlagworte:	AIDS Vaccines - administration & dosage Antigenic Variation Envelope HIV Infections - genetics HIV Infections - immunology HIV-1 - genetics Human immunodeficiency virus Human immunodeficiency virus 1 Humans Models, Immunological Mutation Synthetic immunogens Vaccines, Synthetic - administration & dosage Viral persistence Virulence
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!